Salivary Xanthine Oxidase as a Potential Biomarker in Stroke Diagnostics
Open Access
- 6 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 897413
Abstract
Stroke is one of the most common cerebrovascular diseases. Despite significant progress in understanding stroke pathogenesis, cases are still increasing. Thus, laboratory biomarkers of stroke are sought to allow rapid and non-invasive diagnostics. Ischemia-reperfusion injury is an inflammatory process with characteristic cellular changes leading to microvascular disruption. Several studies have shown that hyperactivation of xanthine oxidase (XO) is a major pathogenic factor contributing to brain dysfunction. Given the critical role of XO in stroke complications, this study aimed to evaluate the activity of the enzyme and its metabolic products in the saliva of stroke subjects. Thirty patients in the subacute phase of stroke were included in the study: 15 with hemorrhagic stroke and 15 with ischemic stroke. The control group consisted of 30 healthy subjects similar to the cerebral stroke patients regarding age, gender, and status of the periodontium, dentition, and oral hygiene. The number of individuals was determined a priori based on our previous experiment (power of the test = 0.8; α = 0.05). The study material was mixed non‐stimulated whole saliva (NWS) and stimulated saliva (SWS). We showed that activity, specific activity, and XO output were significantly higher in NWS of ischemic stroke patients than in hemorrhagic stroke and healthy controls. Hydrogen peroxide and uric acid levels were also considerably higher in NWS of ischemic stroke patients. Using receiver operating curve (ROC) analysis, we demonstrated that XO-specific activity in NWS distinguishes ischemic stroke from hemorrhagic stroke (AUC: 0.764) and controls (AUC: 0.973) with very high sensitivity and specificity. Saliva collection is stress-free, requires no specialized medical personnel, and allows continuous monitoring of the patient’s condition through non-invasive sampling multiple times per day. Salivary XO also differentiates with high accuracy (100%) and specificity (93.75%) between stroke patients with mild to moderate cognitive decline (AUC = 0.988). Thus, salivary XO assessment may be a potential screening tool for a comprehensive neuropsychological evaluation. To summarize, our study demonstrates the potential utility of salivary XO in the differential diagnosis of stroke.Keywords
Funding Information
- Uniwersytet Medyczny w Bialymstoku (SUB/1/DN/22/002/3330)
This publication has 91 references indexed in Scilit:
- Salivary Biomarkers: Toward Future Clinical and Diagnostic UtilitiesClinical Microbiology Reviews, 2013
- Ischemic preconditioning reduces transplanted submandibular gland injuryJournal of Surgical Research, 2013
- Diagnostic Potential of Saliva: Current State and Future ApplicationsClinical Chemistry, 2011
- Mechanisms of ischemic brain damageNeuropharmacology, 2008
- Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemiaPharmacology Biochemistry and Behavior, 2007
- Plasma Oxidants and Antioxidants in Acute Ischaemic StrokeJournal of International Medical Research, 2006
- Reactive oxygen species and the modulation of strokeFree Radical Biology and Medicine, 2005
- Cooperative Catalysis in the Homodimer Subunits of Xanthine OxidaseBiochemistry, 2004
- Malignant transformation‐linked imbalance: Decreased xanthine oxidase activity in hepatomasFEBS Letters, 1975
- Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal ConditionActa Odontologica Scandinavica, 1964